European prostate cancer market is expected to grow at a CAGR of 10.8% during the forecast period. The high prevalence of prostate cancer in the region is one of the major factors for the demand for prostate cancer diagnostics and therapeutics market. As per the World Health Organization, in Europe, around 450,000 new cases of prostate cancer were registered in 2018 in the region. Europe caters around 35% of the global prostate cancer cases, which is highest all across the globe. Moreover, the adoption of innovative technologies for the diagnosis of prostate cancer such as biomarkers and the adoption of personalized medicine for treatment is expected to provide a significant opportunity to the market.
(Get 25% Discount on Buying this Report)
To Request a Sample of our Report on European Prostate Cancer Diagnostic and Therapeutic Market: https://www.omrglobal.com/request-sample/european-prostate-cancer-diagnostic-therapeutic-market
European prostate cancer diagnostic and therapeutic market has been studied on the basis of diagnostic techniques and therapeutics. By diagnostic technique, the market is segmented into prostate-specific antigen test, digital rectal examination, prostate biopsy, imaging techniques. Prostate biopsy is expected to hold a major market share during the forecast period. By therapeutics, the market is segmented into hormonal therapy, chemotherapy, immunotherapy, radiation therapy, targeted therapy, surgery. During the forecast period, chemotherapy is expected to have a major market share in the region. Geographically, the market is divided into Germany, France, UK, Spain, Italy and the Rest of Europe. France and Germany are expected to have a major market share during the forecast period. Around 65,000 new cases in France whereas in Germany around 63,000 new cases of prostate cancer were registered in 2018.
A full Report of European Prostate Cancer Diagnostic and Therapeutic Market is Available @ https://www.omrglobal.com/industry-reports/european-prostate-cancer-diagnostic-therapeutic-market
European Prostate Cancer Diagnostic and Therapeutic Market Segmentation
By Diagnostic Techniques
- Prostate-Specific Antigen Test (PSA)
- Digital Rectal Examination
- Prostate Biopsy
- Imaging Techniques
By Therapeutics
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Radiation Therapy
- Targeted Therapy
- Surgery
Regional Analysis
- Germany
- UK
- France
- Spain
- Italy
Rest of Europe
Company Profiles
- Abbott Laboratories
- AbbVie Products, LLC
- Amgen Inc.
- AstraZeneca PLC
- Bayer AG
- Bristol-Myers Squibb Co.
- Ferring Pharmaceuticals Inc.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Pfizer Inc.
- Siemens Healthcare AG
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
